These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 24045028)
21. Ring Chromosome 10 in a Case of Acute Promyelocytic Leukemia. Shehzad S; Nadeem M; Shan S; Shamsi TS J Coll Physicians Surg Pak; 2016 Nov; 26(11):941-942. PubMed ID: 27981936 [No Abstract] [Full Text] [Related]
22. Effect of genetic profiling on prediction of therapeutic resistance and survival in adult acute myeloid leukemia. Walter RB; Othus M; Paietta EM; Racevskis J; Fernandez HF; Lee JW; Sun Z; Tallman MS; Patel J; Gönen M; Abdel-Wahab O; Levine RL; Estey EH Leukemia; 2015 Oct; 29(10):2104-7. PubMed ID: 25772026 [No Abstract] [Full Text] [Related]
23. Using quantification of the PML-RARalpha transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia. Santamaría C; Chillón MC; Fernández C; Martín-Jiménez P; Balanzategui A; García Sanz R; San Miguel JF; González MG Haematologica; 2007 Mar; 92(3):315-22. PubMed ID: 17339180 [TBL] [Abstract][Full Text] [Related]
24. Expression of CD56 is an unfavorable prognostic factor for acute promyelocytic leukemia with higher initial white blood cell counts. Ono T; Takeshita A; Kishimoto Y; Kiyoi H; Okada M; Yamauchi T; Emi N; Horikawa K; Matsuda M; Shinagawa K; Monma F; Ohtake S; Nakaseko C; Takahashi M; Kimura Y; Iwanaga M; Asou N; Naoe T; Cancer Sci; 2014 Jan; 105(1):97-104. PubMed ID: 24206578 [TBL] [Abstract][Full Text] [Related]
25. [Current therapy for acute myeloid leukemia and acute promyelocytic leukemia]. Miyawaki S Rinsho Ketsueki; 2014 Jan; 55(1):31-41. PubMed ID: 24492035 [No Abstract] [Full Text] [Related]
26. Resistance to arsenic trioxide and retinoic acid therapy in acute promyelocytic leukemia. Zhang X; Pan J Ann Hematol; 2017 Apr; 96(4):707-708. PubMed ID: 28154895 [No Abstract] [Full Text] [Related]
28. Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study. Slack JL; Arthur DC; Lawrence D; Mrózek K; Mayer RJ; Davey FR; Tantravahi R; Pettenati MJ; Bigner S; Carroll AJ; Rao KW; Schiffer CA; Bloomfield CD J Clin Oncol; 1997 May; 15(5):1786-95. PubMed ID: 9164186 [TBL] [Abstract][Full Text] [Related]
29. Continued complete remission after a PML/RAR-alpha+ autograft in acute promyelocytic leukaemia. Ruiz-Argüelles GJ; Garcés-Eisele J; Ruiz-Argüelles A Eur J Haematol; 1996 Mar; 56(3):186-7. PubMed ID: 8598242 [No Abstract] [Full Text] [Related]
30. A 4-gene expression prognostic signature might guide post-remission therapy in patients with intermediate-risk cytogenetic acute myeloid leukemia. Torrebadell M; Díaz-Beyá M; Kalko SG; Pratcorona M; Nomdedeu J; Navarro A; Gel B; Brunet S; Sierra J; Camós M; Esteve J Leuk Lymphoma; 2018 Oct; 59(10):2394-2404. PubMed ID: 29390924 [TBL] [Abstract][Full Text] [Related]
31. [Effect of additional chromosome abnormalities on the outcome of newly diagnosed acute promyelocytic leukemia treated with red arsenic sulfide and all trans-retinoic acid plus anthracyclin based protocol]. Lu J; Jiang H; Jiang Q; Bao L; Lu XJ; Zhang Y; Lin W; Liu YR; Huang XJ; Jiang B Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2254-7. PubMed ID: 19087672 [TBL] [Abstract][Full Text] [Related]
33. Treatment of relapsed acute promyelocytic leukemia with gemtuzumab ozogamicin and all-trans retinoic acid. Tageja N; Valent J; Zonder J J Chemother; 2009 Dec; 21(6):705-6. PubMed ID: 20071299 [No Abstract] [Full Text] [Related]
34. Treatment of elderly adults with acute promyelocytic leukemia: put the pedal to metal. Tallman MS Leuk Lymphoma; 2009 Jan; 50(1):12-3. PubMed ID: 19172497 [No Abstract] [Full Text] [Related]